Condition
Cardiomyopathy, Dilated clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Cardiomyopathy, Dilated clinical trials that are recruiting, at sites in 5 countries (most in Italy (1), Spain (1), Slovenia (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 5Countries
Newest Cardiomyopathy, Dilated clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Cardiac MRI-based prediction tool for outcomes in dilated cardiomyopathy | — | Jinan, Shandong | Recruiting | Apr 14, 2026 |
| RHYthm and Myocardial Function Relationship in Heart Disease | — | Roma | Recruiting | Mar 24, 2026 |
| Registry for hereditary cardiovascular diseases in Brazil | — | Rio Branco, Acre and 26 other locations | Recruiting | Aug 9, 2024 |
| Candesartan treatment for genetic carriers of dilated cardiomyopathy | Phase 3 | Majadahonda, Madrid | Recruiting | Apr 11, 2022 |
| Registry of cell therapy for non-ischemic dilated cardiomyopathy | — | Ljubljana | Recruiting | May 15, 2015 |
All recruiting trials (5)
-
Cardiac MRI-based prediction tool for outcomes in dilated cardiomyopathy
This project will test whether adding multi-parameter stress perfusion cardiac MRI to routine clinical data can better predict which people with dilated cardiomyopathy will go on to develop heart failure, arrhythmias, hospitalizations, or death.
-
RHYthm and Myocardial Function Relationship in Heart Disease
This study tests how heart rhythm patterns relate to heart muscle function in adults with arrhythmias or cardiomyopathy.
-
Registry for hereditary cardiovascular diseases in Brazil
This study is trying to create a registry of Brazilian patients with hereditary heart diseases to see how common certain genetic changes are in people with these conditions.
-
Candesartan treatment for genetic carriers of dilated cardiomyopathy
This study is testing if the medication candesartan can help prevent heart problems in people who carry genes that could lead to dilated cardiomyopathy but don’t have symptoms yet.
-
Registry of cell therapy for non-ischemic dilated cardiomyopathy
This study collects information from patients with non-ischemic dilated cardiomyopathy who received their own cell therapy to see how well it works over time.
Related topics
Quick answers
How many Cardiomyopathy, Dilated clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Italy (1 trial), Spain (1 trial), Slovenia (1 trial), Brazil (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.